Huang, Cheng
Zhu, Xiao-Dong
Shen, Ying-Hao
Xu, Bin
Wu, Dong
Ji, Yuan
Chen, Ling-Li
Song, Tian-Qiang
Zhang, Wei
Zeng, Zhi-Ming
Huang, Hua-Sheng
Wang, Kui
Huang, Lan-Qing
Chen, Yong-Jun
Yang, Yu-Chen
Zhou, Le-Du
Long, Guo
Zhao, Hai-Tao
Wang, Yun-Chao
Ge, Ning-Ling
Chen, Yi
Tan, Chang-Jun
Zhou, Jian
Fan, Jia
Sun, Hui-Chuan
Article History
Received: 10 January 2023
Accepted: 27 April 2023
First Online: 9 May 2023
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and written informed consent was obtained from all patients before inclusion in the study. The study protocol was approved by the Zhongshan Hospital Research Ethics Committee (Approval Numbers: B2020-177R).
: Not applicable.
: Hui-Chuan Sun has received speaker fees from AstraZeneca, Bayer, BeiGene, Eisai, Hengrui, Innovent, MSD, Roche, TopAlliance, and Zelgen, and research grants from Eisai, Innovent, Roche and MSD during the last 5 years. The remaining authors have nothing to declare.